Small molecule high throughput screen using AstraZeneca facilities (Grant)
UK Research and Innovation, Medical Research Council (UK) · National scheme · 1 eligible country
What this scheme funds
This UK scheme funds researchers to run a small molecule high throughput screen using AstraZeneca's compound library and screening robots. It is aimed at identifying new chemical starting points against biological targets, and is open twice a year for any target of interest. Total scheme budget across all recipients is one million pounds.
biotechnology · pharmaceuticals · research-excellence
Do you qualify for this scheme?
Tell us your website and we'll check this scheme's own conditions against what your company does.
Only the website is required.
Who it is for
A UK based academic, non profit or public sector research team with a validated biological target who wants to access AstraZeneca's compound library and screening infrastructure to run an HTS campaign.
The scheme in detail
- Agency
- UK Research and Innovation, Medical Research Council (UK)
- Eligible countries (1)
- United Kingdom
- Funding
- €311k
- Deadline
- 28 Jan 2027
- Applicant type
- Not stated by the agency.
- Eligible applicants
- public sector, non-profit, private sector
- Submission
- Multiple cut-offs (rolling call with several deadlines)
- Also required
- Total scheme budget of £1,000,000 is shared across all recipients, not per applicant, and there are two funding rounds per year open to all targets.